维普中文期刊产品整合服务
11篇 您的检索式:作者名="Ole SN"
    题名 作者 年代 出处 被引量
1Clinical features, management, and prognosis of spontaneous coronary artery dissection显示文摘TWEET MS HAYES SN P1TrA SR et ol 2012Circulation2012,126,5:1
2Transcriptional regulation of lipopolysaccharide (LPS) -induced Toll-like receptor ( TLR ) expres- sion in murine macrophages: role of interferon regulatory factors1 (IRF-1)and 2(IRF-2) 显示文摘Nhu QM Cuesta N Vogel SN et ol 2006Endotoxin Res2006,12,5:1
3In vitro and in vivo effects of progesterone on Trichinella spirolis newborn larvae 显示文摘Nunez GG Gentile T Costantino SN et ol 2005Parasitology2005,131,2:1
4Production of xy- lanase of Bacillus coogulans and its bleaching potential 显示文摘Choudhury B Chauhan S Singh SN et ol 2006World J Microbiol Biotechnol2006,22,3:1
5Nectin-3 links CRHR1 signaling to stress-induced memory deficits and spine loss 显示文摘Wang XD Sn YA Wagner KV et ol 2013Nat Neurosci2013,16,6:1
6Fluconazole inhibits hERG K+ channel by direct block and disruption of protein traf cking 显示文摘Han SN Zhang Y Chen Q et ol 2011Eur J Pharmacol2011,650,1:1
7Mutagenic activity of south Indian food items 显示文摘Sivaswamy SN Balachandran B Sivaramakrishnan VM et ol 1991Indian J Exp Biol1991,29,8:1
8Prevalence and significance of nonsustained ventrieular tachyeardia in patientswith premature ventricular contractions and heart failure treated with vasodilator therapy显示文摘SINGH SN FISHER SG CARSON PE et ol 1998J Am Coil Cardiol1998,,:1
9Isolation of macro- cyclic trichothecenes from a large-scale extract of Baccharis megapotomica 显示文摘Jarvis BB Cfimezoglu SN Rao MM et ol 1987J Org Chem1987,52,1:1
10Chronic ITP:analysis of various factors at presentation which predict failure to first line treatment and their response to second line therapy 显示文摘Syed NN Adil SN Sajid R et ol 2007J Pak Med Assoc2007,57,3:1
11Clinical characteristics and outcomes of nosocomial COVID-19 in Turkey:A retrospective multicenter study显示文摘Objective:To identify the clinical characteristics and outcomes of hospital-acquired SARS-CoV-2 infection during the vaccination period nationwide in Turkey.Methods:COVID-19 patients followed in the pandemic services across Turkey between January 1,2021,and March 31,2022 were investigated retrospectively.Nosocomial COVID-19 was defined as a patient neither diagnosed with COVID-19 nor suspected COVID-19 at the hospital admission and was confirmed COVID-19≥5 days after hospital admission.The primary outcome of this study was in-hospital mortality;demographic features and vaccination status was compared between survivors and non-survivors.Results:During the study period,15573 COVID-19 patients were followed in 18 centers and 543(3.5%)patients were nosocomial COVID-19.Most patients with nosocomial COVID-19(80.4%)were transferred from medical wards.162(29.8%)of the patients with nosocomial COVID-19 admitted to the intensive care unit due to disease severity and 138(25.4%)of the patients died during hospital stay.Advanced age(≥65 years)and number of comorbid diseases(≥2)was found to be associated with mortality in nosocomial COVID-19(OR 1.74,95%CI 1.11-2.74 and OR 1.60,95%CI 1.02-2.56,respectively).Vaccination was associated with survival in nosocomial COVID-19(OR 0.25,95%CI 0.16-0.38).Conclusions:Patients with nosocomial COVID-19 had increased admission to intensive care units and higher mortality rate.Vaccination can decrease the in-hospital mortality rate.Süleyman Yıldırım Celalettin Yılmaz Gülru Polat Serap Argun Baris İlknur Başyiğit İlknur Kaya Ceyda Anar Mihriban Bozkurt HüsnüBaykal Hulya Dirol Gamzenur Ozbey Emine Ozsari Emel Cireli Ali KadriÇırak Dursun Tatar Mine Gayaf Selen Karaoglanoglu Yener Aydin Atilla Eroglu Yıldız Olçar Berna Botan Yıldırım Bengül Gürsoy Deniz Demir Yılmaz Elif Yelda Ozgun Niksarlioglu Ramazan Eren Ayşegül Tomruk Erdem Müge Meltem Tor Fusun Fakili MustafaÇolak Merve Erçelik Ali Tabaru Özlem Ediboglu 2023Asian Pacific Journal of Tropical Medicine2023,16,8:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费